Domov › Rak dojke › Virginia › Richmond
Klinične študije za Rak dojke v Richmond, VA
26 študij za Rak dojke išče udeležence na lokacijah v Richmond in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.
Uradno besedilo študije (angleško)
Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →
The Vanguard Study: Testing a New Way to Screen for Cancer
Vključevanje udeležencevVabljeni zdravi prostovoljci
- VCU Massey Cancer Center at Stony Point, Richmond
- VCU Massey Comprehensive Cancer Center, Richmond
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
Vključevanje udeležencevFaza 3
- Bon Secours Virginia Health System, Midlothian · 11 mi stran
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
- Bon Secours Richmond Community Hospital, Richmond
- Bon Secours Saint Mary's Hospital, Richmond
- Bon Secours Cancer Institute at Reynolds Crossing, Richmond
- in še 3
A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
Vključevanje udeležencevFaza 2
- Virginia Cancer Institute, Richmond
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
Vključevanje udeležencevFaza 3
- VCU Health Adult Outpatient Pavillion ( Site 0070), Richmond
- Bon Secours St. Francis Medical Center-Oncology Research ( Site 0015), Midlothian · 11 mi stran
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
Vključevanje udeležencevFaza 3
- Research Site, Midlothian · 11 mi stran
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
Vključevanje udeležencevFaza 3
- Bon Secours Cancer Institute at St. Francis ( Site 0048), Midlothian · 11 mi stran
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
Vključevanje udeležencevFaza 3
- Clinical Trial Site, Midlothian · 11 mi stran
Cardiovascular Health Education Via Virtual Reality for Breast Cancer Survivors Receiving Anthracyclines or Trastuzumab
Vključevanje udeležencev
- Adult Outpatient Pavilion, Richmond
- Cellular Immunotherapies and Transplant Department, Richmond
- VCU Health at Stony Point, Richmond
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
Vključevanje udeležencevFaza 3
- Bon Secours Cancer Institute at St. Mary's, Richmond
- Bon Secours Cancer Institute at Memorial Regional, Mechanicsville · 6 mi stran
- Bon Secours St. Francis Medical Center, Midlothian · 11 mi stran
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Vključevanje udeležencevFaza 3
- Virginia Cancer Institute, Richmond
A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer
Vključevanje udeležencevFaza 3
- Research Site, Midlothian · 11 mi stran
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Vključevanje udeležencevFaza 3
- Bon Secours Richmond Community Hospital, Richmond
- Bon Secours Saint Mary's Hospital, Richmond
- Bon Secours Cancer Institute at Reynolds Crossing, Richmond
- in še 4
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
Vključevanje udeležencevFaza 2/3
- Bon Secours St. Francis Medical Center, Midlothian · 11 mi stran
E-Mindfulness Approaches for Living After Breast Cancer
Vključevanje udeležencevFaza 3
- Bon Secours Richmond Community Hospital, Richmond
- Bon Secours Saint Mary's Hospital, Richmond
- Virginia Cancer Institute, Richmond
- in še 4
Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)
Vključevanje udeležencev
- Virgina Community University Massey Comprehensive Cancer Center, Richmond
Study to Evaluate the Feasibility of Twice Daily Use of Topical Azelaic Acid in Breast Cancer Patients Undergoing Radiation
Vključevanje udeležencevFaza 1
- Virginia Commonwealth University, Richmond
Pre-Operative Window of ET to Inform RT Decisions (POWER II)
Vključevanje udeležencevFaza 3
- Virginia Commonwealth University, Richmond
Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)
Vključevanje udeležencevFaza 3
- Bon Secours St. Francis Medical Oncology Center, Midlothian · 11 mi stran
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
Vključevanje udeležencevFaza 3
- Bon Secours Cancer Institute at Memorial Regional Medical Center, Mechanicsville · 6 mi stran
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Vključevanje udeležencevFaza 3
- Bon Secours Saint Mary's Hospital, Richmond
- Bon Secours Cancer Institute at Reynolds Crossing, Richmond
- Bon Secours Memorial Regional Medical Center, Mechanicsville · 6 mi stran
- in še 1
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Vključevanje udeležencevOpazovalna študija
- VCU Massey Cancer Center at Stony Point, Richmond
- Virginia Commonwealth University/Massey Cancer Center, Richmond
PAS 1ml Magtrace® for Sentinel Lymph Node Biopsy in Breast Cancer Patients
Vključevanje udeležencevOpazovalna študija
- VCU Massey Comprehensive Cancer Center, Richmond
EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)
Vključevanje udeležencevOpazovalna študija
- VCU Massey Comprehensive Cancer Center, Richmond
- Bon Secours Cancer Institute at St. Francis, Midlothian · 11 mi stran
ASHBY: Accelerated Super-Hypofractionated Breast Brachytherapy
Vključevanje udeležencevFaza 2
- Virginia Commonwealth University, Richmond
CONTIGO - A Narrative Intervention to Enhance Genetic Counseling and Testing
Vključevanje udeležencevVabljeni zdravi prostovoljci
- Virginia Commonwealth University, Richmond
Študije za Rak dojke v drugih mestih
- New York City, NY136 študij
- Houston, TX126 študij
- Boston, MA112 študij
- Nashville, TN81 študij
- Los Angeles, CA73 študij
- Edison, NJ68 študij
- St. Louis, MO64 študij
- Queens, NY64 študij
- Durham, NC64 študij
- Chicago, IL59 študij
- Philadelphia, PA56 študij
- Dallas, TX55 študij
Druge študije v Richmond
- Nemalicelični pljučni rak25 študij
- Rak prostate19 študij
- Srčno popuščanje16 študij
- Rak pljuč14 študij
- Srčno-žilne bolezni13 študij
- Kolorektalni rak13 študij
- Steatotična bolezen jeter12 študij
- Akutna mieločna levkemija12 študij
- Metastatski rak12 študij
- Ploščatocelični karcinom glave in vratu12 študij
- Melanom11 študij
- Debelost11 študij
Vir: ClinicalTrials.gov, podatki pridobljeni 6. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.